Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study. [electronic resource]
Producer: 20100604Description: 286-93 p. digitalISSN:- 1477-030X
- Administration, Sublingual
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Analgesics, Opioid -- administration & dosage
- Cross-Over Studies
- Dizziness -- chemically induced
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Fentanyl -- administration & dosage
- Humans
- Male
- Middle Aged
- Nausea -- chemically induced
- Neoplasms -- complications
- Pain -- drug therapy
- Pain Measurement -- methods
- Placebos
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.